Endothelial dysfunction in development of cerebrovascular disorders in patients with diabetes mellitus
https://doi.org/10.14341/2072-0351-5978
Abstract
Endothelial dysfunction and aberrations of haemostasis play an important part in development of cerebrovascular disorders in patientswith diabetes mellitus. Such factors as hyper- and hypoglycemia, hyperinsulinism, insulin resistance and excessive weight affect progressionof microcirculation deficiency and cerebral ischemia. Transcranial Doppler ultrasound examination is useful as a noninvasivemethod of hemodynamic assessment.
About the Authors
Evgenia Pavlovna Kosobyan
Endocrinology Research Centre, Moscow
Ivona Renata Yarek-Martynova
Endocrinology Research Centre, Moscow
Mikhail Yur'evich Martynov
Russian State Medical University, Moscow
Alla Nikolaevna Yasamanova
Russian State Medical University, Moscow
Tatiana Ivanovna Kolesnikova
Russian State Medical University, Moscow
References
1. Asplund K, Hägg E, Helmers C, Lithner F, Strand T, Wester PO. The natural history of stroke in diabetic patients. Acta Med Scand. 1980;207(5):417-424.
2. Helgason CM. Blood glucose and stroke. Stroke. 1988 Aug;19(8):1049-1105
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035-2038
4. McCall AL The impact of diabetes on the CNS. Diabetes. 1992 May;41(5):557-570.
5. Дедов ИИ, Шестакова МВ. Сахарный диабет. М: Универ- сум Паблишинг; 2003. 209-222 с.
6. Lüscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997 Nov;20(11 Suppl 2):II-3-10.
7. Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation. 1997 Jul 15;96(2):442-447.
8. Домашенко МА. Дисфункция эндотелия в остром периоде ишемического инсульта. Автореф… канд. мед. наук. М, 2006. 31 с.
9. Poston L, Taylor PD. Glaxo/MRS Young Investigator Prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci (Lond). 1995 Mar;88(3):245-255.
10. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thic ness in children with insulindependent diabetes mellitus. J Am Coll Cardiol. 2003 Feb 19;41(4):661-665.
11. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987 Sep;92(1):181-187.
12. He P, Wang J, Zeng M. Leukocyte adhesion and microvessel permeability. Am J Physiol Heart Circ Physiol. 2000 May;278(5):H1686-694.
13. Семенютин ВБ, Свистов ДВ. Методы оценки регуляции мозгового кровотока в нейрохирургии. Российский нейро- хирургический журнал. 2005;(1): 24-25.
14. Thompson BG, Pluta RM, Girton ME, Oldfield EH. Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg. 1996 Jan;84(1):71-78.
15. Lorenzi M, Cagliero E.Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes. 1991 Jun;40(6):653-659.
16. Bamford JM, Warlow CP. Evolution and testing of the lacunar hypothesis. Stroke. 1988 Sep;19(9):1074-1082.
17. Assessment: transcranial Doppler. Report of the American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Neurology. 1990 Apr;40(4):680-681.
18. Vorstrup S, Jensen KE, Thomsen C, Henriksen O, Lassen NA, Paulson OB.Neuronal pH regulation: constant normal intracellular pH is maintained in brain during low extracellular pH induced by acetazolamide--31P NMR study. J Cereb Blood Flow Metab. 1989 Jun;9(3):417-421.
19. Fülesdi B, Limburg M, Bereczki D, Michels RP, Neuwirth G, Legemate D, Valikovics A, Csiba L. Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes. 1997 Nov;46(11):1840-1845.
20. White RP, Deane C, Vallance P, Markus HS. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke. 1998 Feb;29(2):467-472.
21. Pardridge WM, Triguero D, Farrell CR. Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes. 1990 Sep;39(9):1040-1044.
22. Nazir FS, Alem M, Small M, Connell JM, Lees KR, Walters MR, Cleland SJ. Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes. Diabet Med. 2006 Apr;23(4):398-402.
23. Rodriguez G, Nobili F, Celestino MA, Francione S, Gulli G, Hassan K, Marenco S, Rosadini G, Cordera R. Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care. 1993 Feb;16(2):462-468.
24. Pallas F, Larson DF. Cerebral blood flow in the diabetic patient. Perfusion. 1996 Sep;11(5):363-370.
25. Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev. 1992 Jul;8(2):85-103.
26. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond). 2005 Mar;108(3):205-213.
27. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes. 2000 Jul;49(7):1239-1248.
28. Hoffman WH, Pluta RM, Fisher AQ, Wagner MB, Yanovski JA. Transcranial Doppler ultrasound assessment of intracranial hemodynamics in children with diabetic ketoacidosis. J Clin Ultrasound. 1995 Nov-Dec;23(9):517-523.
29. Dandona P, James IM, Woollard ML, Newbury P, Beckett AG. Instability of cerebral blood-flow in insulin-dependent diabetics. Lancet. 1979 Dec 8;2(8154):1203-1205.
30. Fülesdi B, Limburg M, Bereczki D, Molnár C, Michels RP, Leányvári Z, Csiba L. No relationship between cerebral blood flow velocity and cerebrovascular reserve capacity and contemporaneously measured glucose and insulin concentrations in diabetes mellitus. Acta Diabetol. 1999 Dec;36(4):191-195.
31. Pelligrino DA, Albrecht RF. Chronic hyperglycemic diabetes in the rat is associated with a selective impairment of cerebral vasodilatory responses. J Cereb Blood Flow Metab. 1991 Jul;11(4):667-677.
32. Grill V, Gutniak M, Björkman O, Lindqvist M, Stone- Elander S, Seitz RJ, Blomqvist G, Reichard P, Widén L. Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol. 1990 May;258(5 Pt 1):E813-820.
33. Neil HA, Gale EA, Hamilton SJ, Lopez-Espinoza I, Kaura R, McCarthy ST.Cerebral blood flow increases during insulininduced hypoglycaemia in type 1 (insulin-dependent) diabetic patients and control subjects. Diabetologia. 1987 May;30(5):305-309.
34. Hoffman WH, Litaker MS, Pluta RM, Camens ML. Cerebral vasoreactivity in children and adolescents with type 1 diabetes mellitus. Endocr Res. 2004 Aug;30(3):315-325.
35. Eckert B, Ryding E, Agardh CD. Sustained elevation of cerebral blood flow after hypoglycaemia in normal man. Diabetes Res Clin Pract. 1998 May;40(2):91-100.
36. Duckrow RB. Regional cerebral blood flow and glucose utilization during hyperinsulinemia. Brain Res. 1988 Oct 18;462(2):363-366.
37. Hartmann AF, Jaudon JC. Hypoglycaemia. Journal of pediatrics. 1937; ll:19-25.
38. Auer RN, Siesjö BK. Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab. 1993 Jul;7(3):611-625.
39. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JM. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996 Apr 1;93(7):1331-1333.
40. Cooper ME, Gilbert RE, Jerums G. Diabetic vascular complications. Clin Exp Pharmacol Physiol. 1997 Sep- Oct;24(9-10):770-775. [Proc. Austral. Physiol, and Pharmacol. Soc. 1997. - Vol. 28. - № 2. -P.132-141
41. Kamata T, Yokota T, Furukawa T, Tsukagoshi H. Cerebral ischemic attack caused by postprandial hypotension. Stroke. 1994 Feb;25(2):511-513.
42. Robinson TG, Potter JF. Postprandial and orthostatic cardiovascular changes after acute stroke. Stroke. 1995 Oct;26(10):1811-1816.
43. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990 Summer; 2(2):161-192.
44. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, Yue DK, Betteridge DJ, Deanfield JE. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 1996 Sep;28(3):573-579.
45. Ding Y, Vaziri ND, Coulson R, Kamanna VS, Roh DD. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E11-17.
46. Argilés JM, López-Soriano J, Busquets S, López-Soriano FJ. Journey from cachexia to obesity by TNF. FASEB J. 1997 Aug;11(10):743-751.
47. Boulbou MS, Koukoulis GN, Makri ED, Petinaki EA, Gourgoulianis KI, Germenis AE. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol. 2005 Jan;98(1):39-44.
48. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005 Aug;109(2):143-159.
49. Vanhoutte PM. Endothelial dysfunction in hypertension. J Hypertens Suppl. 1996 Dec;14(5):S83-93.
50. Shimokawa H. Endothelial dysfunction in hypertension. J Atheroscler Thromb. 1998;4(3):118-127.
51. Taddei S, Salvetti A. Pathogenetic factors in hypertension. Endothelial factors. Clin Exp Hypertens. 1996 Apr- May;18(3-4):323-335.
52. Taddei S, Virdis A, Ghiadoni L, Salvetti A. The role of endothelium in human hypertension. Curr Opin Nephrol Hypertens. 1998 Mar;7(2):203-209.
53. Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimäki T, Rönnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intimamedia thickness in children with type 1 diabetes. Circulation. 2004 Apr 13;109(14):1750-1755. Epub 2004 Mar 15.
54. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002 May 7;105(18):2231-2239.
55. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulindependent diabetes mellitus. J Am Coll Cardiol. 2003 Feb 19;41(4):661-665.
56. Jin SM, Noh CI, Yang SW, Bae EJ, Shin CH, Chung HR, Kim YY, Yun YS. Endothelial dysfunction and microvascular complications in type 1 diabetes mellitus. J Korean Med Sci. 2008 Feb;23(1):77-82.
57. Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care. 1998 Jun;21(6):1004-1007.
58. Järvisalo MJ, Putto-Laurila A, Jartti L, Lehtimäki T, Solakivi T, Rönnemaa T, Raitakari OT. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes. 2002 Feb;51(2):493-498.
59. Nakanishi N, Suzuki K, Tatara K. Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology. 2003 Sep-Oct;54(5):551-559.
60. Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens. 2004 Mar;13(2):215-223.
61. Щербоносова ТА. Кавинтон в лечении дисциркуляторных церебральных расстройств у пациентов с ожирением. Психиатрия и психофармакотерапия. 2001;3(2):24-25.
62. Kastrup J, Rørsgaard S, Parving HH, Lassen NA. Impaired autoregulation of cerebral blood flow in long-term type I (insulin-dependent) diabetic patients with nephropathy and retinopathy. Clin Physiol. 1986 Dec;6(6):549-559.
63. Albert SG, Gomez CR, Russell S, Chaitman BR, Bernbaum M, Kong BA. Cerebral and ophthalmic artery hemodynamic responses in diabetes mellitus. Diabetes Care. 1993 Feb;16(2):476-482.
64. Petitti DB, Bhatt H. Retinopathy as a risk factor for nonembolic stroke in diabetic subjects. Stroke. 1995 Apr;26(4):593-596.
Review
For citations:
Kosobyan E.P., Yarek-Martynova I.R., Martynov M.Yu., Yasamanova A.N., Kolesnikova T.I. Endothelial dysfunction in development of cerebrovascular disorders in patients with diabetes mellitus. Diabetes mellitus. 2012;15(1):42-48. (In Russ.) https://doi.org/10.14341/2072-0351-5978
Views:
1684
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
